Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced the U.S. Food and Drug ...

Data shows that in the 2023/24 academic year, some 76.7% of girls and 71.2% of boys aged 14 to 15 were vaccinated against HPV ...